Morning Briefing
Summaries of health policy coverage from major news organizations
Glaxo Pays $3 Billion To Settle U.S. Investigations
The settlement will also cover a Department of Justice probe into Glaxo's development and marketing of the diabetes drug Avandia.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
